INS and diabetes mellitus: Retrospective analysis of 1093 patients with well-defined diabetes type (34% Type 1) who had had C-peptide measured in clinical care (duration at C-peptide testing not reported). Type 2 diabetes: clinicians diagnosis and no insulin for 3 years. Type 1 diabetes: clinicians diagnosis and continuous insulin for > 3 years from diagnosis